Fig. 2From: Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemiaWeb-based application for expert elicitation of overall survival between 2 to 5 yearsBack to article page